drugset / Trial / NCT00903357

The Effectiveness of Montelukast on Atopic Dermatitis in Koreans

NCT00903357

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to assess the clinical effectiveness of Montelukast in children (2\~6 years old) with atopic dermatitis and identify the pathophysiologic background of Montelukast on the role of modulating the atopic dermatitis measured by urinary Leukotriene 4 (LTE4) and Eosinophil protein X(EDN).

Timeline

Start
2009-08
Primary completion
2010-08
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 4 mg
Subject Montelukast Other / unclassified 5 mg

Indications